We have shown in a variety of human wounds that collagenase-1 (MMP-1), a matrix metalloproteinase that cleaves fibrillar type I collagen, is invariably expressed by basal keratinocytes migrating across the dermal matrix. Furthermore, we have demonstrated that MMP-1 expression is induced in primary keratinocytes by contact with native type I collagen and not by basement membrane proteins or by other components of the dermal or provisional (wound) matrix. Based on these observations, we hypothesized that the catalytic activity of MMP-1 is necessary for keratinocyte migration on type I collagen. To test this idea, we assessed keratinocyte motility on type I collagen using colony dispersion and colloidal gold migration assays. In both assays, primary human keratinocytes migrated efficiently on collagen. The specificity of MMP-1 in promoting cell movement was demonstrated in four distinct experiments. One, keratinocyte migration was completely blocked by peptide hydroxymates, which are potent inhibitors of the catalytic activity of MMPs. Two, HaCaTs, a line of human keratinocytes that do not express MMP-1 in response to collagen, did not migrate on a type I collagen matrix but moved efficiently on denatured type I collagen (gelatin). EGF, which induces MMP-I production by HaCaT cells, resulted in the ability of these cells to migrate across a type I collagen matrix. Three, keratinocytes did not migrate on mutant type I collagen lacking the collagenase cleavage site, even though this substrate induced MMP-1 expression. Four, cell migration on collagen was completely blocked by recombinant tissue inhibitor of metalloproteinase-1 (TIMP-1) and by affinity-purified anti–MMP-1 antiserum. In addition, the collagen-mediated induction of collagenase-1 and migration of primary keratinocytes on collagen was blocked by antibodies against the α2 integrin subunit but not by antibodies against the α1 or α3 subunits. We propose that interaction of the α2β1 integrin with dermal collagen mediates induction of collagenase-1 in keratinocytes at the onset of healing and that the activity of collagenase-1 is needed to initiate cell movement. Furthermore, we propose that cleavage of dermal collagen provides keratinocytes with a mechanism to maintain their directionality during reepithelialization.
Skip Nav Destination
Article navigation
16 June 1997
Article|
June 16 1997
The Activity of Collagenase-1 Is Required for Keratinocyte Migration on a Type I Collagen Matrix
In Special Collection:
JCB65: Cell Adhesion and Migration
Brian K. Pilcher,
Brian K. Pilcher
*Department of Medicine (Dermatology), ‡Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110; and §Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts 02114
Search for other works by this author on:
Jo Ann Dumin,
Jo Ann Dumin
*Department of Medicine (Dermatology), ‡Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110; and §Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts 02114
Search for other works by this author on:
Barry D. Sudbeck,
Barry D. Sudbeck
*Department of Medicine (Dermatology), ‡Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110; and §Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts 02114
Search for other works by this author on:
Stephen M. Krane,
Stephen M. Krane
*Department of Medicine (Dermatology), ‡Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110; and §Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts 02114
Search for other works by this author on:
Howard G. Welgus,
Howard G. Welgus
*Department of Medicine (Dermatology), ‡Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110; and §Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts 02114
Search for other works by this author on:
William C. Parks
William C. Parks
*Department of Medicine (Dermatology), ‡Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110; and §Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts 02114
Search for other works by this author on:
Brian K. Pilcher
*Department of Medicine (Dermatology), ‡Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110; and §Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts 02114
Jo Ann Dumin
*Department of Medicine (Dermatology), ‡Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110; and §Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts 02114
Barry D. Sudbeck
*Department of Medicine (Dermatology), ‡Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110; and §Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts 02114
Stephen M. Krane
*Department of Medicine (Dermatology), ‡Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110; and §Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts 02114
Howard G. Welgus
*Department of Medicine (Dermatology), ‡Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110; and §Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts 02114
William C. Parks
*Department of Medicine (Dermatology), ‡Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110; and §Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts 02114
1. Abbreviations used in this paper: HU, hydroxyurea; MMP, metalloproteinase; SCID, severe combined immunodeficiency; TIMP-1, tissue inhibitor of metalloproteinases-1.
Address all correspondence to William C. Parks, Ph.D., Division of Dermatology, Barnes-Jewish Hospital, 216 S. Kingshighway, St. Louis, MO 63110. Tel.: (314) 454-7543. Fax: (314) 454-5372. E-mail: [email protected]
Received:
October 28 1996
Revision Received:
November 27 1996
Online ISSN: 1540-8140
Print ISSN: 0021-9525
1997
J Cell Biol (1997) 137 (6): 1445–1457.
Article history
Received:
October 28 1996
Revision Received:
November 27 1996
Citation
Brian K. Pilcher, Jo Ann Dumin, Barry D. Sudbeck, Stephen M. Krane, Howard G. Welgus, William C. Parks; The Activity of Collagenase-1 Is Required for Keratinocyte Migration on a Type I Collagen Matrix. J Cell Biol 16 June 1997; 137 (6): 1445–1457. doi: https://doi.org/10.1083/jcb.137.6.1445
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement
Advertisement